Dr Reddys Laboratories Share Price Today - Live Blog for July 23, 2025

After a notable 0.21% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,248.10. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

With a remarkable 0.06% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,247.00. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.3100, while the industry's PE ratio is 35.8055.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.13% increase and currently trading at ₹1,246.35 per share. Investors are taking notice of this upward momentum.

Following a noteworthy 0.21% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,244.45. When it comes to valuation, this stock has a PE ratio of 18.3100, with the industry PE ratio at 35.8055.

Dr Reddys Laboratories Ltd's share price has fallen by -0.16%, a situation worth noting. At present, the stock is trading at ₹1,239.35. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.3100, while the industry PE ratio is 35.8055.

Dr Reddys Laboratories Ltd's share price rallied by 0.06%, reaching the current market price of ₹1,241.35. This surge is indicative of the stock's recent positive performance.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.08%, reaching the current market price of ₹1,241.50. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.08% dip in its share price and is currently trading at ₹1,240.50. The stock has a PE ratio of 18.3100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.11% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,241.50 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.04% dip in its share price and is currently trading at ₹1,241.30. The stock has a PE ratio of 18.3100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares experienced a -0.02% reduction, with the current market price at ₹1,241.80. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's stock price surged by 0.28%, reaching the current market value of ₹1,240.40 per share. This surge is a testament to the stock's recent performance.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.01% upswing and is currently trading at ₹1,236.90, indicating strong market sentiment.

Dr Reddys Laboratories Ltd's share price has fallen by -0.10%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,236.80, and market participants are assessing the implications. The stock has a PE ratio of 18.3100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd is facing a -0.10% decline and is currently trading at ₹1,236.80 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

With a remarkable 0.09% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,238.00. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.3100, while the industry's PE ratio is 35.8055.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.09%. At this moment, it's actively trading at ₹1,238.00, presenting an enticing opportunity for those in the market.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.03% increase and currently trading at ₹1,235.60 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd witnessed a notable 0.09% surge in its share price and is presently trading at ₹1,235.25, captivating the attention of market participants.

The share price of Dr Reddys Laboratories Ltd plunged by -0.03%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,235.05, but investors are assessing whether this is a temporary dip or a long-term trend.

The share price of Dr Reddys Laboratories Ltd experienced a -0.33% slump and is currently trading at ₹1,236.15. While the stock maintains a PE ratio of 18.3100, the industry PE is 35.8055, raising questions about valuation.

Demonstrating a commendable 0.01% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,241.95. In terms of valuation, the stock maintains a PE ratio of 18.3100, while the industry PE ratio stands at 35.8055.

Dr Reddys Laboratories Ltd experienced a substantial 0.01% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,241.95, making it an appealing option for investors.

Following a noteworthy 0.20% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,238.50. When it comes to valuation, this stock has a PE ratio of 18.3100, with the industry PE ratio at 35.8055.

Dr Reddys Laboratories Ltd's share price has dropped by -0.27%, a development that warrants careful analysis. Presently trading at ₹1,235.50, investors are assessing whether this presents an opportunity or a risk.

The share price of Dr Reddys Laboratories Ltd plunged by -0.31%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,238.15, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd share price has declined by -0.31%, and it's currently trading at ₹1,238.15. The stock maintains a PE of 18.3100, while the industry PE is 35.8055, prompting discussions about its valuation.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.05%. At this moment, it's actively trading at ₹1,241.00, presenting an enticing opportunity for those in the market.